Find clinical trials in your area

Search by disease and location to discover available clinical trials matching your criteria.

Matched clinical trials

  • Study on the Effectiveness of Etoposide, Carboplatin, and Cisplatin in Patients with Localized Digestive Neuroendocrine Carcinomas

    Not yet recruiting

    2 1 1 1
    France
  • Study on PET/CT Imaging with [18F]-AlF-FAPI-74 for Identifying Fibrosis and Inflammation in Patients with Progressive Pulmonary Fibrosis

    Not yet recruiting

    1 1 1
    Investigated diseases:
    Investigated drugs:
    The Netherlands
  • Study on the Safety and Effectiveness of AL8326 for Patients with Small Cell Lung Cancer Needing Second-Line Treatment

    Not yet recruiting

    2 1 1
    Investigated diseases:
    Investigated drugs:
    Italy Spain
  • Study on the Effects of Dexpramipexole for Adolescents and Adults with Severe Eosinophilic Asthma

    Not yet recruiting

    3 1 1
    Czechia
  • Study on HIV-1 Treatment for Patients New to Therapy: Comparing Doravirine/Islatravir with a Drug Combination

    Not yet recruiting

    3 1 1
    France Germany Italy The Netherlands Poland Spain
  • Study on the Effects of XTMAB-16 and Prednisolone in Patients with Pulmonary Sarcoidosis with or without Other Body Involvement

    Not yet recruiting

    1 1 1
    Investigated diseases:
    Czechia Denmark Greece Italy Poland Spain
  • Study on Durvalumab with Chemotherapy for Patients with Advanced Biliary Tract Cancer

    Not yet recruiting

    3 1 1 1
    France Germany Italy Spain
  • Safety Study of NB-4746 with Riluzole and Placebo in Adults with Amyotrophic Lateral Sclerosis (ALS)

    Not yet recruiting

    1 1
    Investigated drugs:
    Italy The Netherlands Poland Spain
  • Randomized Study of Intravitreal mk-8748 Compared with Aflibercept in Patients with Neovascular Age‑Related Macular Degeneration

    Not yet recruiting

    4 1 1 1
    Investigated diseases:
    Investigated drugs:
    Estonia Germany Latvia Poland Spain
  • Montelukast Sodium for disease-modifying treatment in patients with mild‑moderate Parkinson’s disease: open‑label phase II extension study

    Not yet recruiting

    3 1 1 1
    Investigated drugs:
    Sweden